Product
Mometasone Furoate + Formoterol Fumarate
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects With Persistent Asthma Previously Treated With Medium-Dose Inhaled GlucocorticosteroidsStatus: Completed, Estimated PCD: 2008-09-01